Beneficial effects of modulated electro-hyperthermia during neoadjuvant treatment for locally advanced rectal cancer

References

• Swellengrebel H, Marijnen C, Verwaal V, et al. Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer. Br J Surg. 2011;98(3):418–426.
   PubMed Web of Science ®Google Scholar
• Wust P, Kortüm B, Strauss U, et al. Non-thermal effects of radiofrequency electromagnetic fields. Sci Rep. 2020;10(1):1–8.
   PubMed Web of Science ®Google Scholar
• Minnaar CA, Kotzen JA, Ayeni OA, et al. The effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: early results from a phase III randomised controlled trial. PLoS One. 2019;14(6):e0217894.
   PubMed Web of Science ®Google Scholar
• Gadaleta-Caldarola G, Infusino S, Galise I, et al. Sorafenib and locoregional deep electro-hyperthermia in advanced hepatocellular carcinoma: a phase II study. Oncol Lett. 2014;8(4):1783–1787.
   PubMed Web of Science ®Google Scholar
• Ferrari V, De Ponti S, Valcamonico F, et al. Deep electro-hyperthermia (EHY) with or without thermo-active agents in patients with advanced hepatic cell carcinoma: phase II study. J Clin Oncol. 2007;25(18_suppl):15168–15168.
   Google Scholar
• Hager D. Survival and quality of life of patients with advanced pancreatic cancer. Proc Am Soc Clin Oncol. 2002;21:2359.
   Google Scholar
• Hager ED, Sahinbas H, Groenemeyer DH, et al. Prospective phase II trial for recurrent high-grade gliomas with capacitive coupled low radiofrequency (LRF) hyperthermia. J Clin Oncol. 2008;26(15_suppl):2047–2047.
   Web of Science ®Google Scholar
• Andocs G, Szasz O, Szasz A. Oncothermia treatment of cancer: from the laboratory to clinic. Electromagn Biol Med. 2009;28(2):148–165.
   PubMed Web of Science ®Google Scholar
• You S, Kim S. Feasibility of modulated electro-hyperthermia in preoperative treatment for locally advanced rectal cancer: early phase 2 clinical results. Neoplasma. 2020;67(3):677–683.
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–1474.
   PubMed Web of Science ®Google Scholar
• Kim DY, Jung KH, Kim TH, et al. Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2007;67(2):378–384.
   PubMed Web of Science ®Google Scholar
• Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12(1):19–23.
   PubMed Web of Science ®Google Scholar
• Park SH, Kim JC. Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules. Radiat Oncol J. 2016;34(2):96–105.
   PubMed Web of Science ®Google Scholar
• Rau B, Wust P, Hohenberger P, et al. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial. Ann Surg. 1998;227(3):380–389.
   PubMed Web of Science ®Google Scholar
• Schroeder C, Gani C, Lamprecht U, et al. Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone. Int J Hyperthermia. 2012;28(8):707–714.
   PubMed Web of Science ®Google Scholar
• Yoon SM, Kim DY, Kim TH, et al. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2007;69(4):1167–1172.
   PubMed Web of Science ®Google Scholar
• Elming PB, Sørensen BS, Oei AL, et al. Hyperthermia: the optimal treatment to overcome radiation resistant hypoxia. Cancers. 2019;11(1):60.
   PubMed Web of Science ®Google Scholar
• Chaplin D, Durand R, Olive P. Acute hypoxia in tumors: implications for modifiers of radiation effects. Int J Radiat Oncol Biol Phys. 1986;12(8):1279–1282.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist. 2004;9(S5):4–9.
   PubMed Web of Science ®Google Scholar
• Mallory M, Gogineni E, Jones GC, et al. Therapeutic hyperthermia: the old, the new, and the upcoming. Crit Rev Oncol Hematol. 2016;97:56–64.
   PubMed Web of Science ®Google Scholar
• Andocs G, Renner H, Balogh L, et al. Strong synergy of heat and modulated electromagnetic field in tumor cell killing. Strahlenther Onkol. 2009;185(2):120–126.
   PubMed Web of Science ®Google Scholar
• Szasz A, Vincze G, Szasz O, et al. An energy analysis of extracellular hyperthermia. Electromagn Biol Med. 2003;22(2–3):103–115.
   Web of Science ®Google Scholar
• Gani C, Schroeder C, Heinrich V, et al. Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer. Int J Hyperthermia. 2016;32(2):187–192.
   PubMed Web of Science ®Google Scholar
• De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, et al. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Sys Rev. 2009;(3):CD006269.
   Google Scholar
• Qin W, Akutsu Y, Andocs G, et al. Modulated electro-hyperthermia enhances dendritic cell therapy through an abscopal effect in mice. Oncol Rep. 2014;32(6):2373–2379.
   PubMed Web of Science ®Google Scholar
• Minnaar CA, Kotzen JA, Ayeni OA, et al. Potentiation of the abscopal effect by modulated electro-hyperthermia in locally advanced cervical cancer patients. Front Oncol. 2020;10:376.
   PubMed Web of Science ®Google Scholar
• Chi M-S, Mehta MP, Yang K-L, et al. Putative abscopal effect in three patients treated by combined radiotherapy and modulated electrohyperthermia. Front Oncol. 2020;10:254.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Hoff P, Harper P, et al. Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br J Cancer. 2004;90(6):1190–1197.
   PubMed Web of Science ®Google Scholar